HDFC Bank Limited Common Stock vs McKesson Corporation — how do they compare? HDFC Bank Limited Common Stock trades at $22.21 (market cap $110.31B), while McKesson Corporation trades at $930 (market cap $108.46B). The key difference: HDFC Bank Limited Common Stock and McKesson Corporation are close in size by market cap, and HDFC Bank Limited Common Stock pays the higher dividend (1.86%). Which is the better fit depends on your goals — on Pluang, investors hold HDFC Bank Limited Common Stock for 0 Days and McKesson Corporation for 74 Days on average.
| HDB | MCK | |
|---|---|---|
Market Cap | $110.31B | $108.46B |
Volume | 13,548,204 | 712,607 |
Sector | Financials | Health |
52-Week High | $37.18 | $995.69 |
52-Week Low | $21.84 | $725.17 |
Typical Hold Time | 0 Days | 74 Days |
Enterprise Value | $14.19T | $115.00B |
Dividend Yield | 1.86% | 0.4% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
McKesson Corporation (MCK) trades at $910.33, down 1.23% today, but maintains strong analyst support with 80.65% buy ratings and a $956.43 consensus price target. The stock shows bullish technical momentum with recent earnings beats and a major distribution agreement extension with CVS Health through 2032. Revenue growth has accelerated from $264B in 2022 to $359B in 2025, though net margins remain thin at 1.12%.
MCK presents a compelling growth story with consistent earnings outperformance and strategic partnerships driving long-term visibility. However, investors face risks from margin compression, drug pricing pressures, and high leverage with negative shareholder equity. The current valuation at 24.42x P/E appears reasonable given the company's market leadership and oncology growth prospects.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
HDFC Bank provides retail, wholesale, and treasury banking services in India. Its offerings include deposits, lending, payments, trade finance, and financial services for individuals and businesses.
Read more on HDB →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →